Home › Topics › Urinary Incontinence
Urinary Incontinence
GMJ News knowledge hub · last reviewed August 2026 · Georgian Medical Journal
SummaryStatisticsGlossaryGMJ newsFAQDocumentsOrganizationsResearch
Urinary incontinence affects an estimated hundreds of millions of people worldwide, with prevalence in women rising from around 20-30% in young adulthood to over 40% in later life, yet it remains among the most under-reported conditions in medicine — surveys consistently show that most affected people never mention it to a clinician, delaying help-seeking by years and accepting substantial restriction of work, exercise, travel and social life as inevitable (WHO). The clinical imperative is to distinguish stress incontinence (leakage on cough, laugh or exertion, from urethral sphincter or support failure) from urgency incontinence (leakage preceded by an overwhelming urge, from detrusor overactivity), because the treatments diverge completely; and to recognise that supervised pelvic floor muscle training for at least three months is first-line for stress and mixed incontinence with cure or improvement rates that rival surgery, making it one of the most cost-effective and most under-delivered interventions in women's health.
Key messages
Massively under-reported — most people never mention it
Urinary incontinence affects hundreds of millions worldwide, with prevalence in women rising from around 20-30% in young adulthood to over 40% in later life, and it is among the most under-reported conditions in medicine. Surveys consistently find that the majority of affected people never raise it with a clinician, with average delays of several years, and that many accept substantial restriction of work, exercise, travel, sexual activity and social life as an inevitable part of ageing or childbearing. Asking directly — a single screening question in relevant consultations — is therefore one of the highest-yield actions available.
Distinguish stress from urgency incontinence — treatments diverge completely
Stress incontinence: leakage on coughing, laughing, sneezing, lifting or exercise, without urge, caused by failure of urethral support or sphincter function — typically after childbirth, with obesity, or after prostate surgery in men. Urgency incontinence: leakage preceded by a sudden compelling desire to void that cannot be deferred, caused by detrusor overactivity, and usually accompanied by frequency and nocturia (together termed overactive bladder). Mixed incontinence has both. Overflow incontinence: continuous or post-void dribbling from chronic retention. Distinguishing these is the entire basis of management, and can usually be done from history plus a bladder diary alone.
Supervised pelvic floor muscle training is first-line — and rivals surgery
At least three months of SUPERVISED pelvic floor muscle training is first-line for stress and mixed incontinence in women, with cure or improvement rates that approach those of surgery in appropriately selected patients. The word supervised is critical: written instructions or a verbal explanation alone produce far poorer results, because a substantial proportion of women contract the wrong muscles — frequently bearing down instead of lifting — when taught without assessment. Digital assessment or biofeedback by a trained physiotherapist or continence nurse to confirm correct technique, followed by a structured progressive regimen, is what generates the benefit. It is among the most cost-effective and most under-delivered interventions in women's health.
Overactive bladder — bladder training first, then mirabegron over anticholinergics in older adults
For urgency incontinence and overactive bladder, first-line is behavioural: bladder training with scheduled voiding and progressive interval extension, urge suppression techniques, caffeine reduction and appropriate fluid management. Drug therapy follows. Antimuscarinics (solifenacin, tolterodine, oxybutynin) are effective but carry dry mouth, constipation, blurred vision and — importantly — cognitive burden: cumulative anticholinergic exposure is associated with increased dementia risk in large observational studies, and oxybutynin in particular should be avoided in older adults. Mirabegron, a beta-3 agonist, is preferred in this group, with blood pressure monitoring. Refractory cases: intradetrusor botulinum toxin (with a real risk of retention requiring self-catheterisation), percutaneous or implanted sacral neuromodulation.
The mesh sling controversy — accuracy matters in both directions
Midurethral synthetic slings were, and in many countries remain, effective and durable treatments for stress incontinence. However, serious complications — chronic pelvic and groin pain, dyspareunia, mesh exposure and erosion, and difficult removal — affected a significant minority, and inadequate consent, poor complication reporting and dismissal of patients' symptoms compounded the harm. Several countries suspended or restricted use, and inquiries (notably the UK Cumberlege review) documented systemic failure to listen to patients. The clinical implications: full disclosure of alternatives including autologous fascial sling, colposuspension and urethral bulking agents; surgery only by appropriately trained surgeons within registries with mandatory outcome reporting; and access to specialist mesh-removal centres for affected patients.
Always exclude reversible causes and red flags first
Before attributing incontinence to a chronic mechanism, exclude reversible contributors — usefully remembered as DIAPPERS: Delirium; Infection (urinary tract infection); Atrophic vaginitis; Pharmaceuticals (diuretics, alpha-blockers, sedatives, anticholinergics, calcium channel blockers, ACE inhibitors via cough); Psychological; Excess urine output (diabetes, hypercalcaemia, heart failure, excessive fluid or caffeine); Restricted mobility; Stool impaction. Red flags requiring urgent referral: visible or persistent non-visible haematuria; a pelvic mass; suspected fistula (continuous leakage, especially after pelvic surgery, radiotherapy or obstructed labour); new neurological symptoms including any suggestion of cauda equina; and voiding difficulty with a significant post-void residual.
Key statistics
20-40%+
prevalence in women, rising with age; men affected mainly after prostate surgery and with age
ICS/WHOMost never tell
the majority of affected people never raise incontinence with a clinician — ask directly
ICS/ICIAvoid oxybutynin
in older adults — anticholinergic cognitive burden; prefer mirabegron
NICE/Beers criteriaDIAPPERS
mnemonic for reversible causes that must be excluded before chronic management
ICS/GeriatricsContinuous leak
after obstructed labour or pelvic surgery suggests fistula — requires specialist referral
WHO/FIGOStress incontinence in women — approximate cure or improvement rates
Glossary of key terms
Latest GMJ coverage
Articles will appear here as the archive grows.
Frequently asked questions 12 Q&A — structured for Google featured snippets and AI discovery
Knowledge hub: guidelines, conventions and reports
Organizations working in migration and health
Related health topics
Pelvic floor dysfunctionMale LUTS and storage symptomsPost-prostatectomy incontinenceGenitourinary syndrome of menopauseIncontinence, falls and frailtyObstetric fistula and birth injury
About this hub. Produced by the GMJ News Editorial Team as a public-good service. Every statistic is linked to its primary source. Documents are preserved in the GMJ Repository with full attribution. Georgian Medical Journal · Contact the editorial team

